|

Translational
Medicine for Improved Outcomes and Increased Profit
Translational medicine,
the practice of turning bench science into bedside practice, has
been challenging since the beginning of medicine. The federal
government and health care policy makers have been wrestling with
how to drive warranted changes through the health care system to
improve patient outcomes, increase medical treatment effectiveness
and ultimately lower the costs of care.
The current "solutions" to this problem have had dismal results and
the public policy solution chosen has been to ration care and reduce
payments to health care providers. These policies in turn have
caused their own problems including reduced access to medical
treatment, delays in implementation of improved medical treatments,
and higher costs to the system because of deteriorating patient
outcomes.
Profit to the hospital and to the treating physicians is truly the
best way to implement bench science into bedside practice. If
discoveries can decrease patient stay, decrease physician and health
care provider time commitments, while greatly improving patient
outcomes, they can be adopted quickly. This will be accelerated
where the physicians and stockholders receive a profit reward
quickly. A new complete system generally must be ten times better
than what it replaces (horses to automobiles.) Lesser discoveries
can be marginally better. Oxygen saturation qualifies as 10x better
than existing therapies alone. It is potentially as synergistic as
the discovery of the integrated circuit (computer chip.)
Based upon well-characterized but little known bench science and
preliminary applications the HOPS system the IHMF is proposing can
be expected: to improve patient outcomes; decrease physician time
and potentially reduce the length of hospital stays; reduce the
number and length of stay of outlier patients that can sap the
bottom line. These challenges are especially a problem at small
community based hospitals and hospitals with high levels of Medicare
and Medicaid or Medi-CAL patients. Based upon preliminary
evaluations, HOPS contains protocols for emergency room patients,
patients receiving surgery and for patients known to have markers
for becoming outliers. The HOPS system, fully implemented, is
anticipated to reduce physician time and hospital stay time by
one-third or more, while reducing patient recovery time by over one
third.
Long term profit is also important. It is estimated that it will
take the third party payment system between 10 and 15 years to
adjust to the technology proposed, leaving the pioneers in
innovation implementation a considerable span of time to profit from
and gain a reputation as an innovative solution provider that offers
patients higher quality of care than is available at other
locations.
Instruction about participating in on-going Translational Medicine
Studies available to the practitioner to increase hyperbaric medical
center revenue and prestige in the surrounding community
NBIRR-01: Mild-Moderate TBI or PTSD, 18-65: Restoring
Brain Injured Veterans, NFL Players & Police Officers and others to
more productive lives
HAPI: The Hyperbaric Amputation Prevention Initiative: Working
to provide the Centers for Medicare & Medicaid Services (CMS) with
the data they requested on Wagner Grade I & II Wounds to help
prevent amputations. Under a translational medicine study,
Medicare and state Medicaid will pay for patient treatment
HOPS: Hospital Outcomes & Profit System: Integrating
Hyperbaric Medicine into Hospital routine patient care for increased
recovery and lower costs to the hospital.
Practical assistance and guidance on how to be a problem solver for
your professional colleagues and public policy makers
Help federal, state and local policy makers to solve entitlement
program costs, incarceration, and high costs of ineffective
education.
Gain the respect of your professional colleagues by helping them
understand how oxygen saturation technology (hyperbaric oxygen
therapy) can improve their patient's outcomes and increase
efficiency while reducing malpractice exposure.
|